JMS Powered by Bentham

Current Chemical Genomics and Translational Medicine

ISSN: 2213-9885 (Online)
eISSN: (Print)

Current Chemical Genomics and Translational Medicine is an open access online journal, which publishes full-length original research articles, and short research articles (letters) on all advances on drug discovery, translational research, and interaction of chemicals with human genomes and proteins of these genes encoded. Topics covered include: integrative approaches at the chemistry/biology interface, studies related to drug action and mechanism, and translation of basic research knowledge to clinical methods/medicines for the treatment of human diseases. In addition, this journal also covers new technologies and methods for drug development and translational research as well as drug target identification, disease modeling with iPS cells, new disease models, new informatics tools, and biomarker development.

Current Chromatography

ISSN: 2213-2406 (Online)
eISSN: 2213-2414 (Print)

Current Chromatography is an international peer-reviewed journal, which publishes expert reviews, original research articles and thematic issues in all core areas of separation science. The scope of the journal includes chromatography, electrophoresis, and other related analytical methods. The journal aims to cover major advances in both basic and applied separation science of relevance to chemical and biomedical disciplines.

Current Clinical Pharmacology

ISSN: 1574-8847 (Online)
eISSN: 2212-3938 (Print)

Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology. The journal aims to publish the highest quality review articles, drug clinical trial studies and guest edited thematic issues in the field. Topics covered include: pharmacokinetics; therapeutic trials; adverse drug reactions; drug interactions; drug metabolism; pharmacoepidemiology; and drug development. The journal is essential reading for all researchers in clinical pharmacology.

Current Computer-Aided Drug Design

ISSN: 1573-4099 (Online)
eISSN: 1875-6697 (Print)

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews, original research articles and letter articles written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.

Current Dentistry

ISSN: 2542-579X (Online)
eISSN: 2542-5803 (Print)

Current Dentistry, a peer-reviewed journal, publishes original research, expert reviews, and thematic issues in all areas of dental, oral and craniofacial sciences including biological, clinical, materials engineering and bioengineering aspects of dental research. The journal will be of interest to researchers in dental, oral, hard-tissue, and craniofacial science.

Current Diabetes Reviews

ISSN: 1573-3998 (Online)
eISSN: 1875-6417 (Print)

Current Diabetes Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited issues on all the latest advances on diabetes and its related areas dedicated to clinical research e.g. pharmacology, pathogenesis, complications, epidemiology, clinical care and therapy. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.

Current Drug Abuse Reviews

ISSN: (Online)
eISSN: 1874-4745 (Print)

Current Drug Abuse Reviews aims to publish the highest quality reviews, meta-analyses and drug clinical trial studies on all latest advances on alcohol and drug abuse and addiction. Book reviews are also published. The Journal will further comprise an agenda listing relevant meetings and conferences that will take place in near future, and advertisement.

Current Drug Delivery

ISSN: 1567-2018 (Online)
eISSN: 1875-5704 (Print)

Current Drug Delivery aims to publish peer-reviewed articles, research articles, short and in-depth reviews, and drug clinical trials studies in the rapidly developing field of drug delivery. Modern drug research aims to build delivery properties of a drug at the design phase, however in many cases this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves. The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical and chemical methods. The drugs include a wide range of bioactive compounds from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides and sugars. The journal will also report progress in the fields of transport routes and mechanisms including efflux proteins and multi-drug resistance. The journal is essential for all pharmaceutical scientists involved in drug design, development and delivery.

Current Drug Discovery Technologies

ISSN: 1570-1638 (Online)
eISSN: 1875-6220 (Print)

Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing original research papers, reviews, drug clinical trial studies and guest edited thematic issues describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process. Current Drug Discovery Technologies is an essential journal for all scientists and research managers involved in drug discovery who wish to keep abreast of all the modern techniques and technologies used in drug discovery.

Current Drug Safety

ISSN: 1574-8863 (Online)
eISSN: 2212-3911 (Print)

Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.

Current Drug Therapy

ISSN: 1574-8855 (Online)
eISSN: 2212-3903 (Print)

Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy and drug clinical trial studies and guest edited thematic issues covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.

Current Environmental Engineering

ISSN: 2212-7178 (Online)
eISSN: 2212-7186 (Print)

Current Environmental Engineering is a peer-reviewed journal that publishes expert reviews, research articles and topical issues on all the major advances in environmental engineering. Current Environmental Engineering covers the applications of environmental engineering and scientific discoveries on waste water management and control, water, air and soil pollution, human habitation, water disposal, recycling, radiation protection, industrial hygiene, environmental law and policies, public health, and environmental sustainability. The journal is of particular interest for professionals, academics, researchers and policy makers, working in the field of environmental engineering.

Current Enzyme Inhibition

ISSN: 1573-4080 (Online)
eISSN: 1875-6662 (Print)

Current Enzyme Inhibition aims to publish original research, review and letter articles in all the latest and outstanding developments on enzyme inhibition studies. The coverage includes the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Current Enzyme Inhibition is an essential journal for every pharmaceutical researcher and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Current Gene Therapy

ISSN: 1566-5232 (Online)
eISSN: 1875-5631 (Print)

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of genetic diseases. Cell therapy manuscripts can also include application in non-genetic diseases when cells have been genetically modified. Current Gene Therapy publishes reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of genetic diseases. Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.

Current Genomics

ISSN: 1389-2029 (Online)
eISSN: 1875-5488 (Print)

Current Genomics is a peer-reviewed journal that provides essential reading for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments in genome science and systems modeling. Current Genomics publishes three types of peer-reviewed articles including: i) High-quality research papers reporting on new and original data generated at the genome scale level, including meta-analysis studies. Systems biology, molecular systems modeling, molecular evolution, developmental biology, aging research and human disease research are topics of particular interest. Position papers dealing with new or complex methodological approaches whether experimental or mathematical are greatly welcome in this section. ii) Authoritative and comprehensive reviews from widely-recognized experts, covering all the latest and outstanding developments in genome science and computational/systems biology. Proposals for mini-hot topics (2-3 review papers) and full hot topics (6-8 review papers) are welcome in this section and they should not contain original data. Guest edited issues provide expert views on specific questions giving an extensive and comprehensive analysis of a specific field of activities in genomics. All aspects of genetic analysis and gene function will be covered, particularly in the growing areas of human genomics, functional genomics and next generation sequencing, molecular evolution, developmental biology, aging research and systems/statistical modeling. iii) Opinion papers from internationally and widely recognized experts addressing contemporary questions and issues in the field of genome science and systems biology and basic and clinical research practices.